Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EndoBionics Inc.

This article was originally published in Start Up

Executive Summary

EndoBionics Inc.'s wire-guided microneedle catheter can traverse the vascular system to inject drugs into deep tissues and major organs, areas that have heretofore been hard to reach in a minimally invasive manner. The company's long-term goal is regenerative medicine, but EndoBionics will seek nearer-term revenues from a first application in coronary restenosis, positioning its MicroSyringe as an alternative to drug-eluting stents.

Related Content


Related Companies

Related Deals




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts